Discovery of an autoinhibited conformation in mesotrypsin reveals a strategy for selective serine protease inhibition
Selective inhibition of the more than 100 S1 family serine proteases is a long-standing challenge due to their active site similarity. Mesotrypsin, implicated in cancer progression, exemplifies these difficulties; no current inhibitors achieve selectivity over other human trypsins. We found an unexpected autoinhibited conformation of mesotrypsin via x-ray crystallography, revealing a cryptic pocket adjacent to the active site. Using high-throughput virtual screening targeting this cryptic pocket, we identified a conformationally selective small-molecule inhibitor that stabilizes the inactive state of mesotrypsin. This inhibitor demonstrates selectivity for mesotrypsin over other trypsins. Our findings challenge the accepted view of digestive trypsins as constitutively active enzymes lacking potential for allosteric regulation. Furthermore, analyses of other structures suggest that dynamic sampling of closed states with analogous allosteric cryptic pockets appears widespread among S1 serine proteases. These observations point to a potentially generalizable strategy to achieve selective inhibition, offering broad implications for drug development targeting serine proteases in cancer and other diseases.
- Research Organization:
- Lawrence Berkeley National Laboratory (LBNL), Berkeley, CA (United States)
- Sponsoring Organization:
- US Department of Energy; USDOE Office of Science (SC), Basic Energy Sciences (BES) (SC-22), Scientific User Facilities Division (SC-22.3 )
- Grant/Contract Number:
- AC02-05CH11231
- OSTI ID:
- 2583658
- Journal Information:
- Science Advances, Journal Name: Science Advances Journal Issue: 27 Vol. 11
- Country of Publication:
- United States
- Language:
- English
Similar Records
Halogen bonding for the design of inhibitors by targeting the S1 pocket of serine proteases
The P 2 ' residue is a key determinant of mesotrypsin specificity: Engineering a high-affinity inhibitor with anticancer activity
Mesotrypsin has evolved four unique residues to cleave trypsin inhibitors as substrates [Mesotrypsin has evolved to cleave trypsin inhibitors as substrates using four unique residues]
Journal Article
·
Sun Aug 05 20:00:00 EDT 2018
· RSC Advances
·
OSTI ID:2470011
The P 2 ' residue is a key determinant of mesotrypsin specificity: Engineering a high-affinity inhibitor with anticancer activity
Journal Article
·
Mon Nov 14 23:00:00 EST 2011
· Biochemical Journal
·
OSTI ID:1069432
Mesotrypsin has evolved four unique residues to cleave trypsin inhibitors as substrates [Mesotrypsin has evolved to cleave trypsin inhibitors as substrates using four unique residues]
Journal Article
·
Mon Jul 13 20:00:00 EDT 2015
· Journal of Biological Chemistry
·
OSTI ID:1341510